Department Of Health, Goldshield Settlement, UK
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Medical Malpractice / Litigation; Public Health
Article Date: 26 Jun 2007 - 1:00 PDT
email to a friend 
printer friendly 
view / write opinions 
rate article
The Department of Health and Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Limited ("Goldshield") are pleased to jointly announce settlement of the claims brought against Goldshield for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs.
Under the terms of the settlement Goldshield have agreed, on a full and final basis and without admission of liability, to pay the NHS the sum of £4 million and to provide co-operation in connection with the continuing civil claims regarding the alleged price fixing arrangements. Both Goldshield and the Department of Health look forward to a strong working relationship in the future.
Department of Health, UK
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Pharma Industry / Biotech Industry headlines email to a friend printer friendly version
weekly newsletter daily news alerts
personalize your news
rss feeds
back to top
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |
